Latest headlines
AbbVie News
The latest AbbVie (ABBV) news, aggregated as it breaks. News moves sentiment and sentiment moves price, so read these ABBV headlines next to the live AbbVie Fear and Greed Index.
Latest AbbVie Headlines46
ABBV Stock Dips 4% Despite Robust Q2: Buy the Dip or Stay Cautious?
zacks.com · Aug 6, 2026
This Stock Keeps Raising Its Dividend No Matter What the Market Does -- and Wall Street Thinks It's a Buy Right Now
fool.com · Aug 5, 2026
Is It Worth Investing in AbbVie (ABBV) Based on Wall Street's Bullish Views?
zacks.com · Aug 5, 2026
Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX® Cosmetic for Masseter Muscle Prominence
prnewswire.com · Aug 4, 2026
ABBV Q2 Earnings Call Balances Growth With Apogee Dilution
zacks.com · Aug 3, 2026
AbbVie: Strong Q2 And New Catalysts Keep Me Bullish
seekingalpha.com · Aug 3, 2026
Why AbbVie Stock Slumped Today
fool.com · Jul 31, 2026
AbbVie Inc. (ABBV) Q2 2026 Earnings Call Transcript
seekingalpha.com · Jul 31, 2026
AbbVie Inc (ABBV) (Q2 2026) Earnings Call Highlights: Robust Growth Driven by Skyrizi and Rinvoq, Pipeline Advances
gurufocus.com · Jul 31, 2026
ABBV Beats on Q2 Earnings & Sales, Cuts '26 EPS View, Stock Down
zacks.com · Jul 31, 2026
Pre-Market Trading Up in Final Session of the Week
zacks.com · Jul 31, 2026
AbbVie Q2 Earnings Call Highlights
marketbeat.com · Jul 31, 2026
AbbVie (ABBV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
zacks.com · Jul 31, 2026
Which Healthcare ETF Is the Better Buy: Fidelity's FHLC or Invesco's Equal-Weight RSPH?
fool.com · Jul 31, 2026
AbbVie Stock Falls as Guidance Cut Overshadows Strong Q2 Earnings Beat
benzinga.com · Jul 31, 2026
AbbVie Beats but Cuts Guidance on $10.9 Billion Acquisition
gurufocus.com · Jul 31, 2026
AbbVie (ABBV) Q2 Earnings and Revenues Beat Estimates
zacks.com · Jul 31, 2026
AbbVie Lowers Outlook to Account for Acquisition as Profit Jumps
wsj.com · Jul 31, 2026
AbbVie Bought Apogee to Strengthen Its Portfolio. Now It's Cutting Earnings Guidance.
barrons.com · Jul 31, 2026
AbbVie trims 2026 profit forecast on Apogee buy, beats second-quarter estimates
reuters.com · Jul 31, 2026
AbbVie Reports Second-Quarter 2026 Financial Results
prnewswire.com · Jul 31, 2026
Apogee Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apogee Therapeutics, Inc. - APGE
gurufocus.com · Jul 30, 2026
Apogee Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apogee Therapeutics, Inc. - APGE
businesswire.com · Jul 30, 2026
JUVÉDERM® Day Returns to U.S. on August 19
prnewswire.com · Jul 30, 2026
Meet the Stock That's Obliterating Eli Lilly, Johnson & Johnson, and AbbVie Right Now
fool.com · Jul 29, 2026
AbbVie Has Raised Its Dividend for 53 Straight Years and Still Looks Attractively Valued. Is This Dividend King the Smartest Buy in Healthcare Right Now?
fool.com · Jul 29, 2026
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
prnewswire.com · Jul 29, 2026
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo
prnewswire.com · Jul 29, 2026
Should You Buy, Hold or Sell ABBV Stock Ahead of Q2 Earnings?
zacks.com · Jul 28, 2026
Should You Buy AbbVie Stock Hand Over Fist Before July 31?
fool.com · Jul 27, 2026
Sarepta names former Abbvie president as CEO as Ingram retires
reuters.com · Jul 27, 2026
Better Dividend King to Buy Right Now: AbbVie or Johnson & Johnson?
fool.com · Jul 26, 2026
Why Wall Street Can't Get Enough of This Dividend King
fool.com · Jul 25, 2026
AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
zacks.com · Jul 24, 2026
AbbVie: A Dividend Fortress At An Appealing Price Tag
seekingalpha.com · Jul 24, 2026
Netflix, AbbVie, Cerebras Systems And An Energy Stock On CNBC's ‘Final Trades'
benzinga.com · Jul 24, 2026
Genmab and AbbVie Provide Clarification on Phase 3 EPCORE® DLBCL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
businesswire.com · Jul 23, 2026
Which Healthcare ETF Is the Better Buy: Vanguard's VHT or Fidelity's FHLC?
fool.com · Jul 23, 2026
I'd Double a Position in These 3 Dividend Stocks Right Now Without Any Hesitation
fool.com · Jul 23, 2026
Which Is the Better Healthcare ETF: First Trust's High-Conviction FBT or Vanguard's Low-Cost VHT?
fool.com · Jul 23, 2026
Which iShares Healthcare ETF Is the Better Buy: Diversified IXJ or Biotech-Focused IBB?
fool.com · Jul 23, 2026
Will AbbVie's Oncology Franchise Remain Under Pressure in Q2?
zacks.com · Jul 22, 2026
PINK vs. IXJ: Which Health Care ETF Is the Better Buy for Investors?
fool.com · Jul 22, 2026
AbbVie (ABBV) Beats Stock Market Upswing: What Investors Need to Know
zacks.com · Jul 21, 2026
3 Reasons to Buy AbbVie Stock Like There's No Tomorrow
fool.com · Jul 21, 2026
IXJ vs. RSPH: Which Healthcare ETF Is the Better Buy?
fool.com · Jul 21, 2026
Why Is AbbVie Up or Down Today?
When AbbVie (ABBV) moves sharply, the reason is almost always in the headlines above. Earnings, guidance, analyst upgrades and downgrades, product news and macro data are the usual drivers of a ABBV move on the day. The feed shows what broke and when, and the sentiment tag on each story shows whether the coverage skews positive or negative, so you can see at a glance why AbbVie is up or down today.
How AbbVie News Affects the Price
News does not move the AbbVie (ABBV) price directly, it moves sentiment, and sentiment moves price. A run of negative headlines pulls the AbbVie Fear and Greed Index toward fear, while positive coverage pushes it toward greed, often before the price has fully reacted. A surprise story usually shows up first as a spike in AbbVie trading volume. That is the chain to watch: headline, sentiment, volume, then the ABBV price.
Trade the AbbVie News With Sentiment
Headlines tell you what happened; the Fear and Greed Index tells you how the crowd is reacting. Watch AbbVie trading volume spike on a big story, check the AbbVie price history for context, follow the live ABBV price, see the AbbVie price prediction, and read the AbbVie Fear and Greed Index for mood.
How do you feel about AbbVie?
1DFrequently asked questions
Why is AbbVie up or down today?
What is the latest AbbVie news?
Where does AbbVie news come from?
How often is AbbVie news updated?
How does AbbVie news relate to its Fear and Greed Index?
Headlines are aggregated from third-party sources and link to the original publishers. CFGI does not author or endorse them.
About CFGI
The per-asset sentiment record.
CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.
Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.